Instructions: Print this exam worksheet. Return to the course page using the link below. Read the course material. Enter your answers on this worksheet. Return to the course page and click the link 'Take Test.' Transfer your answers.

https://www.quantumunitsed.com/go/1787

Quantum Units Education®

Extended-Release Injectable Naltrexone for the Treatment of Opioid Dependence

1. Not all physicians can prescribe buprenorphine, but naltrexone can be prescribed by any healthcare provider who is licensed to prescribe medications.

A. True

B. False


2. Which of the following is not a controlled substance?

A. Methadone

B. Buprenorphine

C. Naltrexone

D. All of the above are controlled substances


3. Which of the following is an opioid antagonist?

A. Naltrexone

B. Methadone

C. Morphine

D. None of the above


4. At least _____ days without opioid use is recommended before beginning extended-release injectable naltrexone.

A. 1-3

B. 7-10

C. 12-15

D. 15-18


5. Extended-release injectable naltrexone should only be administered intravenously, and should never be administered intramuscularly, subcutaneously, or inadvertently into fatty tissue.

A. True

B. False


6. When surgeries or procedures are planned for patients who use extrended-release injectable naltrexone, it may be safest to delay the procedure until naltrexone blood levels are low enough to restore opioid receptor availability.

A. True

B. False


Copyright © 2024 Quantum Units Education

Visit us at QuantumUnitsEd.com!